H5N1 News: Roche temporarily suspends delivery of Tamiflu to U.S. due to increased demand
An AP newswire article, via MSNBC, reports that:
Swiss pharmaceutical company Roche Holding AG said Thursday it had temporarily suspended shipments of the anti-viral drug Tamiflu in the United States to ensure that enough treatments will be available for the regular influenza season.
Roche spokesman Alexander Klauser said that Roche’s U.S. management suspended the shipments because of the increased global demand for Tamiflu, the drug that experts believe is most effective in treating flu in humans. Demand has increased due to fears of the potential spread of bird flu.
“The priority is that there is enough Tamiflu for the people who need it at the start of the influenza season,” Klauser told The Associated Press. “At the moment, there is no influenza currently circulating.”